guidance

Ignite It
2 min read • March 17, 2020

CV Sciences Analyst Remains Bullish On CBD Company Despite Q4 Miss

Ignite It
5 min read • March 16, 2020

Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week

Ignite It
2 min read • March 10, 2020

Medical CBD Company Zynerba Rallies On Q4 Report, CEO Says 2020 Outlook ‘Promising’

Ignite It
1 min read • February 13, 2020

Aurora Cannabis Reaffirms Q3 Cannabis Sales Guidance ‘will be impacted by previously mentioned industry headwinds, and as such will likely show modest to no growth relative to fiscal Q2’s cannabis revenue’

Ignite It
1 min read • February 13, 2020

Aurora Cannabis Warns ‘due to several short-term factors, there is likely to be a slower than previously expected rate of industry growth in the near-term’

Ignite It
1 min read • February 6, 2020

Aurora Cannabis Says Outlook For Cannabis Revenue Is Expected To Be Impacted By ‘General Industry Headwinds’ And Will Show ‘Little To No Growth’ Relative To Q2 Cannabis Revenue Of $62M-$66M

Ignite It
1 min read • February 6, 2020

Aurora Cannabis Says Cash Cost To Produce Per Gram Of Dried Cannabis Sold s Expected To Remain Below $1

Ignite It
2 min read • February 6, 2020

Aurora Cannabis Sees Prelim. FY20 Sales $62M-$66M; Co. Expects To Record Provisions For Returns, Price Reductions And Future Provisions Of ~$12M

Ignite It
4 min read • February 3, 2020

Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week

Ignite It
2 min read • January 14, 2020

Aphria’s Q2 Cannabis Sales Exceed Cantor Fitzgerald’s Expectations

Ignite It
3 min read • January 8, 2020

Harvest Health Sues Falcon International To Terminate Merger, Accuses Co. Of Interstate Cannabis Transport

Ignite It
3 min read • November 14, 2019

Aurora Cannabis Trades Down As Q1 Loss Balloons, Company Reels In Construction, Expenses

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis earnings
 cannabis farms
 cannabis study
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 Hot
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.